Zeitschriftenaufsatz
|
2007
Use of a genetic cholera toxin B subunit/allergen fusion molecule as mucosal delivery system with immunosuppressive activity against Th2 immune responses.
Autor:in
Bublin, Merima; Hoflehner, Elisabeth; Wagner, Birgit; Radauer, Christian; Wagner, Stefan; Hufnagl, Karin; Allwardt, Dorothee; Kundi, Michael; Scheiner, Otto; Wiedermann, Ursula; Breiteneder, Heimo;
Publikationen als Autor:in / Herausgeber:in der Vetmeduni
Journal
Schlagwörter
Administration, Intranasal; Animals; Antigens, Plant/administration & dosage*; Antigens, Plant/chemistry; Antigens, Plant/genetics; Antigens, Plant/metabolism; Cholera Toxin/administration & dosage*; Cholera Toxin/chemistry; Cholera Toxin/genetics; Cholera Toxin/metabolism; Desensitization, Immunologic/methods*; Disease Models, Animal; Female; Humans; Hypersensitivity, Immediate/immunology; Hypersensitivity, Immediate/therapy*; Immunity, Mucosal; Immunosuppression*; Mice; Mice, Inbred BALB C; Models, Molecular; Mucous Membrane; Recombinant Fusion Proteins/administration & dosage*; Recombinant Fusion Proteins/chemistry; Recombinant Fusion Proteins/genetics; Recombinant Fusion Proteins/metabolism; Th2 Cells/immunology*;
Dokumententyp
Originalarbeit
ISSN/eISSN
0264-410X -
10.1016/j.vaccine.2007.10.003
WoS ID
PubMed ID